Biomedical Polymers: Properties & Applications in Drug Delivery

Added:

Cell-Derived Biomimetic Vehicles vs. Synthetic Polymeric Carriers

While biomedical polymers are widely researched for drug delivery, a growing alternative perspective argues that synthetic polymers face significant clinical translation hurdles, including immunogenicity, complex scale-up, and toxicity from degradation byproducts (such as the acidic accumulation from PLGA). Critics and researchers in the field increasingly advocate for cell-derived biomimetic carriers—such as exosomes, red blood cell membranes, and extracellular vesicles—as superior alternatives. These biological vehicles possess innate biocompatibility, low immunogenicity, and natural targeting capabilities that synthetic polymers struggle to replicate. By bypassing the foreign-body response and avoiding toxic synthetic degradation, cell-based delivery systems present a major paradigm shift that challenges the dominance of traditional polymer engineering in advanced therapeutics.

Basic Polymer Chemistry: Understanding polymerization, molecular weight, and the differences between synthetic and natural polymers.
Fundamentals of Biocompatibility: Knowledge of how the human body reacts to foreign materials, including immune responses and toxicity.
Introductory Pharmacokinetics: Familiarity with drug absorption, distribution, metabolism, and excretion (ADME) profiles.
Physical Chemistry of Materials: Understanding key material properties such as solubility, diffusivity, glass transition temperature (Tg), and degradation mechanisms.
Advanced Nanomedicine: Designing polymeric nanoparticles, micelles, and dendrimers for targeted and intracellular drug delivery.
Stimuli-Responsive Biomaterials: Exploring 'smart' polymers that change properties in response to environmental triggers like pH, temperature, or enzymes.
Scaffolding in Tissue Engineering: Utilizing biodegradable polymers to design 3D matrices for cell growth and tissue regeneration.
Regulatory Science and Translational Medicine: Understanding the FDA approval process, clinical trial phases, and ISO biocompatibility standards for polymeric medical devices.
9.6K views43likes33:49@nptel-indianinstituteofsci8064Original Release: 2019-06-21

Biomedical polymers are classified into synthetic (chemically synthesized for specific medical applications) and natural (derived from organisms like plants or animals) types, each with distinct advantages: synthetic polymers offer tunable properties and easy large-scale production, while natural polymers provide inherent biocompatibility but face supply limitations. Key considerations for biomedical polymer selection include biocompatibility (non-immunogenic, non-toxic), mechanical properties, degradation behavior, and application-specific requirements. Degradation occurs through two primary mechanisms: bulk erosion (water penetrates faster than degradation, causing uniform breakdown) and surface erosion (degradation occurs faster than water penetration, causing systematic thinning). Factors influencing hydrolytic degradation include backbone chemistry (amide bonds degrade faster than esters), crystallinity (amorphous polymers degrade faster), molecular weight, and surface-to-volume ratio.